- Monday, September 9, 2024
-
R.5181 of 2024
Release: 103
G.G.51171 - Friday, September 6, 2024
Schedules of various substances subject to particular conditions and inclusion of new chemical entities
Pages affected2
- Monday, March 11, 2024
-
R.4487 of 2024
Release: 102
G.G.50273 - Friday, March 8, 2024
SEPA of medicines and Scheduled substances for the year 2024
Pages affected1
- Monday, February 26, 2024
-
R.4406 of 2024
Release: 101
G.G.50164 - Friday, February 23, 2024
Exemption of manufacturers, wholesalers & distributors of Class A medical & in vitro diagnostics
Pages affected1
- Monday, September 18, 2023
-
R.3875 of 2023
Release: 100
G.G.49309 - Friday, September 15, 2023
Dispensing fee to be charged by persons licensed in terms of section 22C(1)(a)
Pages affected2
- Monday, August 28, 2023
-
R.3816 of 2023
Release: 99
G.G.49189 - Friday, August 25, 2023
Amendments to Dispensing fee for pharmacists
Pages affected2
- Tuesday, August 22, 2023
-
R.3800 of 2023
Release: 98
G.G.49140 - Friday, August 18, 2023
Exclusion of Schedule Zero (0) medicines from the operations of sections 22G and 18A of the Act
Pages affected1
-
R.3801 of 2023
Release: 98
G.G.49140 - Friday, August 18, 2023
Second single exit price increase (SEPI) of Medicines and Schedule Substances for the year 2023 (Top-Up-SEPI)
Pages affected1
- Thursday, May 11, 2023
-
R.3382 of 2023
Release: 97
G.G.48524 - Friday, May 5, 2023
Exclusion of certain alcohol-based hand-rubs from the operation of specified provisions
Pages affected1
- Thursday, May 4, 2023
-
R.3343 of 2023
Release: 96
G.G.48475 - Tuesday, March 28, 2023
General Regulations made in terms of the Act Amendment, 2023
Pages affected5
- Tuesday, January 24, 2023
-
R.2940 of 2023
Release: 95
G.G.47883 - Friday, January 20, 2023
Annual Single Exit Price Adjustment (SEPA) of Medicines and Scheduled Substances for the year 2023
Pages affected1
- Friday, December 9, 2022
-
R.2853 of 2022
Release: 94
G.G.47673 - Thursday, December 8, 2022
General regulations made in terms of the Medicines and Related Substances Act: Amendment
Pages affected2
- Monday, October 31, 2022
-
R.2685 of 2022
Release: 93
G.G.47373 - Friday, October 28, 2022
South African Health Products Regulatory Authority (SAHPRA), made and updated the Schedules
Pages affected10
- Tuesday, August 30, 2022
-
R.2412 of 2022
Release: 92
G.G.46789 - Friday, August 26, 2022
Amend Schedules
Pages affected2
- Tuesday, August 23, 2022
-
R.2382 of 2022
Release: 91
G.G.46736 - Friday, August 19, 2022
Notification of registration of medicines in terms of section 17 of the Act
Pages affected1
- Tuesday, August 9, 2022
-
R.2342 of 2022
Release: 90
G.G.47197 - Friday, August 5, 2022
Annual Single Exit Price Adjustment (SEPA) of medicines & scheduled substances for the year 2023
Pages affected1
-
R.2343 of 2022
Release: 90
G.G.47197 - Friday, August 5, 2022
Amendment to Dispensing fee to be charged by persons licensed in terms of section 22C(1)(a)
Pages affected2
- Monday, July 11, 2022
-
R.2266 of 2022
Release: 89
G.G.46688 - Friday, July 8, 2022
Regulations relating to a Transparent Pricing System for medicines and Scheduled substances: Dispensing Fee for Pharmacists
Pages affected2
- Monday, February 7, 2022
-
R.1722 of 2022
Release: 88
G.G.45859 - Friday, February 4, 2022
Guidelines to Annual Single Exit Price Adjustments (SEPA) of Medicines and Scheduled Substances for the year 2022
Pages affected1
- Monday, January 10, 2022
-
R.1632 of 2021
Release: 87
G.G.45673 - Friday, December 17, 2021
Extension Notice: Extension to the Exemption of Medical Devices & In-Vitro Diagnostics from the Provisions of Section 18A & Section 18B of the Act
Pages affected1
- Monday, December 13, 2021
-
R.1581 of 2021
Release: 86
G.G.45616 - Friday, December 10, 2021
Exclusion of Schedule 0 medicines from the operation of Sections 22G and 18A of the Act
Pages affected1
- Tuesday, November 16, 2021
-
R.1502 of 2021
Release: 85
G.G.45487 - Monday, November 15, 2021
Exclusion of COVID-19 vaccines from the operation of certain provisions of the Act
Pages affected1
- Monday, September 20, 2021
-
R.883 of 2021
Release: 84
G.G.45176 - Friday, September 17, 2021
Amendments to Schedules
Pages affected25
- Tuesday, August 31, 2021
-
R.756 of 2021
Release: 83
G.G.45057 - Friday, August 27, 2021
Exclusion of certain Alcohol-Based Hand-Rubs from the Operation of Specified Provisions of the Act
Pages affected1
- Monday, March 29, 2021
-
Notice 139 of 2021
Release: 82
G.G.44333 - Friday, March 26, 2021
Regulations relating to a transparent pricing system for medicines and scheduled substances
Pages affected2
-
R.267 of 2021
Release: 82
G.G.44398 - Friday, March 26, 2021
Annual single price adjustment (SEPA) of medicines and scheduled substances for the year 2021
Pages affected1
- Thursday, March 25, 2021
-
R.252 of 2021
Release: 81
G.G.44322 - Thursday, March 25, 2021
Exclusion of Schedule 2, Schedule 3 and Schedule 4 from Certain Provisions of Medicines and Related Substances Act
Pages affected1
- Tuesday, January 12, 2021
-
R.1375 of 2020
Release: 80
G.G.44019 - Friday, December 18, 2020
Updates to Schedules
Pages affected42
-
R.1379 of 2020
Release: 80
G.G.44026 - Tuesday, December 22, 2020
Regulations regarding fees payable in terms of the Act
Pages affected2
- Monday, November 23, 2020
-
R.1233 of 2020
Release: 79
G.G.43913 - Friday, November 20, 2020
Amendment of Government Notice 514: Exclusion of Schedule 2, Schedule 3 and Schedule 4 substances from the Operation of certain Provisions of the Act
Pages affected1
- Monday, June 29, 2020
-
R.721 of 2020
Release: 78
G.G.43484 - Friday, June 26, 2020
Exclusion of Certain Alcohol-Based Hand-Rubs from the Operation of Specified Provisions of the Act
Pages affected1
- Monday, June 22, 2020
-
R.679 of 2020
Release: 77
G.G.43447 - Friday, June 19, 2020
Amendment to Regulations Relating to Transparent Pricing System for Medicines and Schedules Substances: Dispensing Fee for Pharmacists
Pages affected2
- Monday, May 25, 2020
-
R.585 of 2020
Release: 76
G.G.43346 - Friday, May 22, 2020
Exclusion of Medicines, Medical Devices and In Vitro Diagnostics (IVDs) Donated to the State from the Operation of certain Provisions of the Act
Pages affected1
-
R.586 of 2020
Release: 76
G.G.43347 - Friday, May 22, 2020
Amendment to Schedules
Pages affected4
- Monday, May 11, 2020
-
R.514 of 2020
Release: 75
G.G.43294 - Thursday, May 7, 2020
Exclusion of Schedule 2, Schedule 3 and Schedule 4 Substances from the operation of certain Provisions of the Act
Pages affected1
- Thursday, April 30, 2020
-
R.481 of 2020
Release: 74
G.G.43260 - Thursday, April 30, 2020
Exclusion of Schedule 2, Schedule 3 and Schedule 4 Substances from the Operation of Certain Provisions of the Act
Pages affected1
- Monday, March 30, 2020
-
R.322 of 2020
Release: 73
G.G.43110 - Friday, March 20, 2020
Annual Single Exit Price Adjustment (SEPA) of Medicines and Scheduled Substances for the Year 2020.
Pages affected1
-
R.377 of 2020
Release: 73
G.G.43145 - Friday, March 27, 2020
Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances [Dispensing Fee to be charged by Persons Licensed in terms of Section 22C (1)(a)]
Pages affected2
- Monday, March 2, 2020
-
R.219 of 2020
Release: 72
G.G.43051 - Friday, February 28, 2020
Amended Schedules
Pages affected10
-
R.220 of 2020
Release: 72
G.G.43051 - Friday, February 28, 2020
Publishing of Schedules
Pages affected9
- Monday, May 27, 2019
-
R.695 of 2019
Release: 71
G.G.42474 - Friday, May 24, 2019
Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965
Pages affected2
-
R.696 of 2019
Release: 71
G.G.42474 - Friday, May 24, 2019
Exemption of Medical Devices and In-vitro Diagnostics (IVDS) from the Provisions of Sections 18A and 18B of the Act
Pages affected1
- Thursday, May 23, 2019
-
R.755 of 2019
Release: 70
G.G.42477 - Thursday, May 23, 2019
South African Health Regulatory Authority (SAHPRA): Schedules - Amendment
Pages affected6
-
R.756 of 2019
Release: 70
G.G.42477 - Thursday, May 23, 2019
Exclusion of Certain Preparations containing Cannabidiol (CBD) from Operation of Certain Provisions of the Act
Pages affected1
- Monday, May 20, 2019
-
R.685 of 2019
Release: 69
G.G.42465 - Friday, May 17, 2019
Exemption of Medical Devices and In-Vitro Diagnostics (IVDS) from the Provisions of Sections 18A and 18B of the Act
Pages affected1
- Thursday, January 24, 2019
-
R.27 of 2019
Release: 68
G.G.42183 - Wednesday, January 23, 2019
Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee to be Charged by Persons Licensed in terms of Section 22c (1) (A))
Pages affected2
-
R.28 of 2019
Release: 68
G.G.42183 - Wednesday, January 23, 2019
Regulations relating to a transparent pricing system for medicines and scheduled substances: Dispensing fee for pharmacists
Pages affected2
-
R.29 of 2019
Release: 68
G.G.42183 - Wednesday, January 23, 2019
Annual Single Exit Price Adjustment (SEPA) of medicines and scheduled substances for the year 2019
Pages affected1
- Monday, November 26, 2018
-
R.1262 of 2018
Release: 67
G.G.42052 - Friday, November 23, 2018
Amendment of Schedules
Pages affected6
- Tuesday, October 16, 2018
-
R.1098 of 2018
Release: 66
G.G.41971 - Friday, October 12, 2018
Schedules of Various Substance to Particular Conditions and Inclusion of New Chemical Entities in the Schedules
Pages affected5
-
R.1099 of 2018
Release: 66
G.G.41971 - Friday, October 12, 2018
Call Up for Registration of Oral Preparations which Contain a Bacterial Strain(s)
Pages affected1
- Thursday, January 18, 2018
-
R.1479 of 2017
Release: 65
G.G.41362 - Friday, December 29, 2017
Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Amendment
Pages affected2
-
R.1480 of 2017
Release: 65
G.G.41362 - Friday, December 29, 2017
Annual Adjustment of the Single Exit Price of Medicines and Schedule Substances (SEPA) for the Year 2018 and Information to be Provided by Manufacturers and or Importers of Medicines and Scheduled Substances
Pages affected1
-
R.1481 of 2017
Release: 65
G.G.41362 - Friday, December 29, 2017
Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists
Pages affected2
- Wednesday, November 22, 2017
-
R.1261 of 2017
Release: 64
G.G.41256 - Friday, November 17, 2017
Amendment of Schedules
Pages affected9
-
R.1256 of 2017
Release: 64
G.G.41248 - Tuesday, November 14, 2017
Call Up for Registration of Oral Preparations which Contain Bacterial Strains
Pages affected1
- Friday, September 15, 2017
-
R.973 of 2017
Release: 63
G.G.41100 - Friday, September 8, 2017
Correction Notice
Pages affected1
- Thursday, September 7, 2017
-
R.859 of 2017
Release: 62
G.G.41064 - Friday, August 25, 2017
Medicines and Related Substances Act (101/1965): General regulations made in the Schedule
Pages affected2
- Wednesday, August 2, 2017
-
R.748 of 2017
Release: 61
G.G.41009 - Wednesday, July 26, 2017
Amendment of Schedules
Pages affected11
- Monday, June 5, 2017
-
Act 14/2015
Release: 60
G.G.39585 - Friday, January 8, 2016
Medicines and Related Substances Amendment Act 14/2015
Pages affected33
-
Act 72/2008
Release: 60
G.G.32148 - Tuesday, April 21, 2009
Medicines and Related Substances Amendment Act 72/2008
Pages affected50
-
R.20 of 2017
Release: 60
G.G.40869 - Friday, May 26, 2017
Commencement of Medicines and Related Substances Amendment Act 72/2008
Pages affected60
- Wednesday, March 1, 2017
-
R.157 of 2017
Release: 59
G.G.40637 - Friday, February 24, 2017
Notice with regard to Regulations on Medical Devices and In Vitro Diagnostics
Pages affected1
- Wednesday, February 1, 2017
-
R.1589 of 2016
Release: 58
G.G.40515 - Thursday, February 23, 2017
Amendment: Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances
Pages affected2
-
R.48 of 2017
Release: 58
G.G.40577 - Monday, February 27, 2017
Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists
Pages affected2
- Monday, December 12, 2016
-
R.1515 of 2016
Release: 57
G.G.40480 - Friday, December 9, 2016
Regulations relating to Medical Devices and In Vitro Diagnostic Medical Devices (IVDs)
Pages affected1
- Tuesday, September 20, 2016
-
R.1018 of 2016
Release: 56
G.G.40279 - Friday, September 16, 2016
Extension of the Implementation Period of the Interim Adjustment of the Single Exit Price of Medicines and Scheduled Substances (SEPA) for the year 2016
Pages affected1
- Thursday, September 1, 2016
-
R.565 of 2016
Release: 55
G.G.40015 - Wednesday, May 25, 2016
Exclusion of Certain Medicines from the Operation of Certain Provisions of the Medicines and Related Substance Act, 1965
Pages affected1
- Tuesday, July 19, 2016
-
R.761 of 2016
Release: 54
G.G.40094 - Friday, June 24, 2016
Amendment to Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances
Pages affected2
- Thursday, June 23, 2016
-
R.620 of 2016
Release: 53
G.G.40041
Amendment of Schedules
Pages affected10
- Thursday, May 5, 2016
-
R.502 of 2016
Release: 52
G.G.39970 - Wednesday, May 4, 2016
Notice with regard to Preparations which Contain Ibogaine
Pages affected1
- Thursday, March 17, 2016
-
R.25 of 2016
Release: 51
G.G.39594 - Wednesday, January 13, 2016
Information to be Provided by Manufacturers and or Importers of Medicines and Scheduled Substances when Applying for the Single Exit Price Adjustment for 2016
Pages affected1
-
R.352 of 2014
Release: 51
G.G.37622 - Thursday, May 8, 2014
Schedules: Amendment
Pages affected7
-
R.234 of 2015
Release: 51
G.G.38586 - Friday, March 20, 2015
Amendment to the Schedules
Pages affected8
-
R.254 of 2016
Release: 51
G.G.39815 - Tuesday, March 15, 2016
Updating of Schedules on the recommendation of the Medicines Control Council
Pages affected9
- Tuesday, February 9, 2016
-
R.153 of 2016
Release: 50
G.G.39658 - Friday, February 5, 2016
Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists
Pages affected2
- Monday, September 7, 2015
-
R.784 of 2015
Release: 48
G.G.39154 - Tuesday, September 1, 2015
Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965
Pages affected1
- Thursday, August 20, 2015
-
R.734 of 2015
Release: 47
G.G.39114 - Wednesday, August 19, 2015
Undesirable Medicine
Pages affected1
-
R.735 of 2015
Release: 47
G.G.39114 - Wednesday, August 19, 2015
Undesirable Medicines
Pages affected1
-
R.739 of 2015
Release: 47
G.G.39121 - Thursday, August 20, 2015
Undesirable Medicine
Pages affected1
- Wednesday, May 13, 2015
-
R.345 of 2015
Release: 46
G.G.38731 - Thursday, April 23, 2015
Amendment - Dispensing Fee to be Charged by Persons Licensed in terms of the Medicines and Related Substances Act, 1965
Pages affected2
- Tuesday, March 17, 2015
-
R.211 of 2015
Release: 45
G.G.38566 - Monday, March 16, 2015
Regulations relating to the Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists
Pages affected3
- Wednesday, November 12, 2014
-
R.837 of 2014
Release: 43
G.G.38133 - Tuesday, October 28, 2014
Notice with regard to Oral Preparations
Pages affected1
- Friday, August 8, 2014
-
R.609 of 2014
Release: 42
G.G.37898 - Thursday, August 7, 2014
Notice with regard to Undesirable Medicine - Phenyl Butazone
Pages affected1
- Thursday, March 27, 2014
-
R.104 of 2014
Release: 41
G.G.37318 - Tuesday, February 11, 2014
Amendment to Schedules
Pages affected7
- Thursday, February 6, 2014
-
R.870 of 2013
Release: 40
G.G.37032 - Friday, November 15, 2013
Amendment - General Regulations made in terms of the Medicines and Related Substances Act, 1965
There are no pages referenced by this update
- Thursday, October 24, 2013
-
R.766 of 2013
Release: 39
G.G.36929 - Monday, October 14, 2013
Amendment to General Regulations as published under R.510 of 2003
There are no pages referenced by this update
-
R.690 of 2013
Release: 39
G.G.36850 - Friday, September 20, 2013
Amendment to Schedules as published under R.935 of 2008 - Updating of the Schedules
Pages affected7
-
R.674 of 2013
Release: 39
G.G.36827 - Friday, September 13, 2013
Amendment to Schedules as published under R.935 of 2008 - Updating of the Schedules
Pages affected7
- Thursday, October 3, 2013
-
R.714 of 2013
Release: 38
G.G.36875 - Thursday, September 26, 2013
Amendment to R.1102 of 2005 - Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances
Pages affected2
- Thursday, May 2, 2013
-
R.321 of 2013
Release: 37
G.G.36412 - Thursday, April 25, 2013
Resolution Approved by the Minister of National Health
Pages affected1
- Friday, February 8, 2013
-
R.68 of 2013
Release: 36
G.G.36118 - Friday, February 1, 2013
Publication of the Guidelines for Pharmacoeconomic Submissions
Pages affected1
- Friday, January 25, 2013
-
R.1026 of 2012
Release: 35
G.G.35947 - Thursday, December 6, 2012
Disposal of Undesirable Medicine
Pages affected1
- Friday, March 23, 2012
-
R.227 of 2012
Release: 33
G.G.35149 - Thursday, March 15, 2012
Amendment to the Schedules
Pages affected8
- Monday, January 31, 2011
-
R.1256 of 2010
Release: 30
G.G.33906 - Friday, December 24, 2010
Regulations relating to the Transparent Pricing System for Medicines and Scheduled Substances: Amendment
Pages affected2
- Tuesday, November 30, 2010
-
R.1090 of 2010
Release: 29
G.G.33775 - Friday, November 19, 2010
Regulations relating to the Transparent Pricing System for Medicines and Scheduled Substances: Amendment
Pages affected2
- Monday, May 31, 2010
-
R.389 of 2010
Release: 28
G.G.33177 - Wednesday, May 12, 2010
General Regulations made in terms of the Act - Amendment
There are no pages referenced by this update
- Friday, April 30, 2010
-
R.284 of 2010
Release: 27
G.G.33102 - Friday, April 16, 2010
Withdrawal Notice
Pages affected1
-
R.290 of 2010
Release: 27
G.G.33110 - Tuesday, April 13, 2010
Information to be Furnished by Manufacturers and Importers of Medicines and Scheduled Substances before Applying an Increase to the Single Exit Price
Pages affected1
-
R.208 of 2010
Release: 27
G.G.33034 - Wednesday, March 17, 2010
Determination of Maximum Increase in the Single Exit Price of Medicines and Scheduled Substances for 2010
Pages affected1
- Wednesday, March 31, 2010
-
BN.20 of 2010
Release: 26
G.G.32965 - Friday, February 26, 2010
Unprofessional Conduct: Use of Injection Therapy by Chiropractors
Pages affected1